Last update 30 Oct 2025
Tingo Regenerative Medicine Technology Co., Ltd

Tingo Regenerative Medicine Technology Co., Ltd

Subsidiary Company|2010|Tianjin Shi, China

Overview

Tags

Respiratory Diseases
Infectious Diseases
Exosomes
Prophylactic vaccine
mRNA vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Exosomes1
Prophylactic vaccine1
mRNA vaccine1
Top 5 TargetCount
SARS-CoV-2 S protein1

Related

1
Drugs associated with Tingo Regenerative Medicine Technology Co., Ltd
Milk Exosome-mRNA Oral COVID-19 Vaccine (Exosome Technology)
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein inhibitors
Active Org.
Tingo Regenerative Medicine Technology Co., LtdTingo Regenerative Medicine Technology Co., Ltd [+1]
Originator Org.
Tingo Exosomes Technology Co., Ltd
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Tingo Regenerative Medicine Technology Co., Ltd
Login to view more data
0 Patents (Medical) associated with Tingo Regenerative Medicine Technology Co., Ltd
Login to view more data
100 Deals associated with Tingo Regenerative Medicine Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Tingo Regenerative Medicine Technology Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Milk Exosome-mRNA Oral COVID-19 Vaccine (Exosome Technology)
 ( SARS-CoV-2 S protein )		COVID-19
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free